SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased community activity ahead of the upcoming Goliath mainnet launch, which investors are positioning as a critical infrastructure catalyst for the project. While some holders express optimism about long-term institutional adoption and price potential, others remain skeptical, citing concerns over historical price volatility, opaque development communication, and the recurring pattern of quick pumps followed by sharp pullbacks.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors aggressively debate whether its recent market valuation qualifies it for inclusion in the Russell 1000 index, sparking significant options activity and intense volatility. Community sentiment remains polarized, with bulls pointing to the company's long-term potential in cancer treatment and upcoming clinical catalysts, while bears remain skeptical of index inclusion and warn of potential pullbacks.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor shares are facing intense downward pressure following a double-digit percentage drop triggered by the announcement of an all-stock acquisition of Synaptics. While long-term bulls argue the move strengthens the company's position in physical AI and edge computing, the community is currently debating the immediate impact of shareholder dilution and the messy market optics of the deal structure.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing heightened volatility and intense investor speculation fueled by recurring buyout rumors and end-of-quarter index rebalancing. While many in the community debate the company's valuation and leadership performance, the stock remains a focal point for traders tracking clinical trial progress and potential strategic M&A interest.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant momentum driven by a strong oncology pipeline, potential regulatory tailwinds for its mRNA flu vaccine, and positive sentiment following an FDA advisory committee endorsement. Investors are actively debating the company's valuation, weighing its ambitious clinical milestones against ongoing political scrutiny and historical market volatility.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors digest the recent hiring of a seasoned Chief Commercial Officer and anticipate upcoming pivotal Phase 3 study initiations for its NSCLC program. The community remains hyper-focused on the stock's potential as a buyout candidate, with many viewing recent volatility and low volume as institutional accumulation ahead of key regulatory milestones later this year.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is trending as investors rotate into the stock following a series of analyst upgrades and positive late-stage clinical developments, including regulatory progress for its oncology pipeline and expanded indications for key CAR T-cell therapies. The community remains focused on the companys ability to successfully navigate impending patent cliffs through its aggressive pursuit of strategic partnerships and R&D-driven growth.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending as investors weigh a $35 buyout offer against a significant shipping rate boom, with community discussion intensely focused on whether the deal will successfully close amid geopolitical tensions. Many are debating the stock's potential as a 'dividend machine' while actively monitoring the arbitrage spread and potential for higher counter-bids.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is trending as investors weigh its pivot into full-stack AI factory infrastructure against intense community debate over its short-term price stability. While supporters highlight the companys strategic status as an NVIDIA AI Factory Specialized Partner and growing enterprise demand, skeptics are actively raising concerns about potential volatility and the sustainability of recent rallies.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is currently experiencing significant volatility following news that a major data center project in Wyoming has been paused, sparking debate among investors about the stock's valuation and long-term trajectory. While short-term traders are reacting to bearish options flow and technical pullbacks, the community remains divided between those capitalizing on the high volatility and those maintaining a long-term bullish thesis on Bloom's role in the AI power infrastructure bottleneck.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
